RE: [External email] Sad news about Dr. Ludden
Dear All:
In Dr. Ludden we lost an excellent scientist who helped to revolutionize and advance clinical pharmacokinetics, pharmacometrics, clinical pharmacology, and drug development. I’m indebted to him for the impact he made on my life as a pharmacometrician, clinical pharmacologist, and drug developer while working with him at the FDA. He started the Pharmacometrics Staff Unit which became Pharmacometrics Division in later years.
May his soul rest in peace.
Sincerely,
Ene.
Sent from
Mail
for Windows
Quoted reply history
From:
Diane Mould
Sent:
Friday, August 2, 2024 4:03 PM
To:
Riley, Steve
;
[email protected]
Subject:
RE: [External email][NMusers] Sad news about Dr. Ludden
Dear All
I am very saddened to hear this news. Tom Ludden was one of the nicest and smartest people that I have ever known. He was a gentle giant in our field and I will miss him.
Best
Diane
From:
[email protected]
<
[email protected]
>
On Behalf Of
Riley, Steve
Sent:
Friday, August 2, 2024 2:41 PM
To:
[email protected]
Subject:
[External email][NMusers] Sad news about Dr. Ludden
CAUTION:
This email originated from outside the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.
Dear NM-Users,
Regrettably, I am writing to let you know that Dr. Ludden passed away Tuesday evening, 30JUL2024. I was able to get there over the weekend prior to visit him and his family.
During his wakeful moments we had some good scientific discussions.
We talked a lot about NONMEM and how its functionality and utility has expanded since he retired. He was pleased to hear about the changes. He was surrounded by family for the days leading up to the end. They were all appreciative that I was able to get there and tell him (and them) how much he meant to all of us and the impact he had on our careers.
I think memories of Dr. Ludden were characterized perfectly by Marc Gastonguay, “I am forever grateful for the positive impact that Tom had on my life and career, not to mention the tremendous, although often underappreciated, contributions he made to the disciplines of clinical pharmacology and pharmacometrics. His humble brilliance will be missed and fondly remembered.”
Steve Riley